128 related articles for article (PubMed ID: 11213940)
1. Multicenter trial of prolonged infusions of rocuronium bromide in critically ill patients: effects of multiple organ failure.
Circeo LE; Reeves ST
South Med J; 2001 Jan; 94(1):36-42. PubMed ID: 11213940
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
[TBL] [Abstract][Full Text] [Related]
3. The effect of isoflurane versus balanced anesthesia on rocuronium's pharmacokinetics and infusion requirement.
Larijani GE; Gratz I; Afshar M; McDonald PA; Fisher DM
Pharmacotherapy; 1995; 15(1):36-41. PubMed ID: 7739943
[TBL] [Abstract][Full Text] [Related]
4. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
5. Dose requirements of continuous infusion of rocuronium and atracurium throughout orthotopic liver transplantation in humans.
Weng XC; Zhou L; Fu YY; Zhu SM; He HL; Wu J
J Zhejiang Univ Sci B; 2005 Sep; 6(9):869-72. PubMed ID: 16130187
[TBL] [Abstract][Full Text] [Related]
6. The neuromuscular effects of 0.6 mg kg(-1) rocuronium in elderly and young adults with or without renal failure.
Kocabas S; Yedicocuklu D; Askar FZ
Eur J Anaesthesiol; 2008 Nov; 25(11):940-6. PubMed ID: 18538050
[TBL] [Abstract][Full Text] [Related]
7. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
[TBL] [Abstract][Full Text] [Related]
8. Neuromuscular pharmacodynamics of rocuronium in patients with major burns.
Han T; Kim H; Bae J; Kim K; Martyn JA
Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics and pharmacokinetics of rocuronium following continuous infusion in patients during intravenous anaesthesia.
Sparr HJ; Khuenl-Brady KS; Eriksson LI
Eur J Anaesthesiol Suppl; 1994; 9():63-5. PubMed ID: 7925211
[TBL] [Abstract][Full Text] [Related]
10. An Evaluation of Continuous Infusion Rocuronium for Sustained Neuromuscular Blockade in Critically Ill Adults.
Groetzinger LM; Hutchins AT; Rivosecchi RM
Ann Pharmacother; 2021 Jun; 55(6):732-737. PubMed ID: 33043678
[TBL] [Abstract][Full Text] [Related]
11. Rocuronium bromide in the ICU: dose finding and pharmacokinetics.
Khuenl-Brady KS; Sparr H; Pühringer F; Agoston S
Eur J Anaesthesiol Suppl; 1995 Sep; 11():79-80. PubMed ID: 8557012
[TBL] [Abstract][Full Text] [Related]
12. Increased cis-atracurium requirements during prolonged administration to a child.
Tobias JD
Can J Anaesth; 1997 Jan; 44(1):82-4. PubMed ID: 8988829
[TBL] [Abstract][Full Text] [Related]
13. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
[TBL] [Abstract][Full Text] [Related]
14. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular recovery following rocuronium bromide single dose in infants.
Rapp HJ; Altenmueller CA; Waschke C
Paediatr Anaesth; 2004 Apr; 14(4):329-35. PubMed ID: 15078379
[TBL] [Abstract][Full Text] [Related]
16. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
Rex C; Wagner S; Spies C; Scholz J; Rietbergen H; Heeringa M; Wulf H
Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the differences in the time to onset of action between rocuronium and vecuronium.
Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Salmerón J
Clin Exp Pharmacol Physiol; 2006; 33(1-2):125-30. PubMed ID: 16445711
[TBL] [Abstract][Full Text] [Related]
18. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
Pühringer FK; Rex C; Sielenkämper AW; Claudius C; Larsen PB; Prins ME; Eikermann M; Khuenl-Brady KS
Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
[TBL] [Abstract][Full Text] [Related]
19. Low incidence of multiple organ failure after major trauma.
Laudi S; Donaubauer B; Busch T; Kerner T; Bercker S; Bail H; Feldheiser A; Haas N; Kaisers U
Injury; 2007 Sep; 38(9):1052-8. PubMed ID: 17572416
[TBL] [Abstract][Full Text] [Related]
20. Priming rapacuronium: a comparison with rocuronium and mivacurium.
Steinberg D
Acta Cient Venez; 2003; 54(2):115-20. PubMed ID: 14976782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
